Fig. 10

In vivo experiments including (A percentage change of bodyweight in animal and B anti-tumor efficacy and C survival curve) of formulations (PBS, free DOX, Taxotere, free drugs combination DOX:DTX 1:1 and all PM formulation) in female BALB/c mice-bearing 4T1 tumor after post injection of 5:5 mg/kg DOX and DTX (****indicates the P value < 0.0001). All formulation compared with PBS